Conversely, an increase in the DNA content of BMP6-treated MMs was observed between 2 and 4 weeks, resulting in significantly higher DNA levels relative to that of control OM MMs at weeks 4 and 6 (Fig. 5A; n = 6, p < 0.0001). This evidence concerns the gene BMP6 and ocular melanoma.